Browsing by Author "Dursun, P"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
Item Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group studyGuvenal, T; Dursun, P; Hasdemir, PS; Hanhan, M; Guven, S; Yetimalar, H; Goksedef, BP; Sakarya, DK; Doruk, A; Terek, MC; Saatli, B; Guzin, K; Corakci, A; Deger, E; Celik, H; Cetin, A; Ozsaran, A; Ozbakkaloglu, A; Kolusari, A; Celik, C; Keles, R; Sagir, FG; Dilek, S; Uslu, T; Dikmen, Y; Altundag, O; Ayhan, AObjective. The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging. Methods. In a retrospective Turkish multicenter study, 539 patients, from 14 institutions, with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan-Meier method. Results. The median age at diagnosis was 40 years (range 15-84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (735%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (545%) have undergone surgical staging procedures. Of the patients who underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1-120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival. Conclusion. Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management. (C) 2013 Elsevier Inc. All rights reserved.Item A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancerDursun, P; Erkanli, S; Güzel, AB; Gultekin, M; Tarhan, NC; Altundag, O; Demirkiran, F; Bese, T; Yildirim, Y; Bozdag, G; Yarali, H; Simsek, T; Ozcelik, B; Ortaç, F; Taskin, S; Guvenal, T; Ozgul, N; Haberal, A; Vardar, MA; Dede, M; Yenen, M; Altintas, A; Arvas, M; Ayhan, AObjective: To analyze the results of fertility-sparing treatment of early-stage endometrial cancer (EC) in patients treated at Turkish gynecologic oncology centers, and to present a review of the literature. Methods: Thirteen healthcare centers in Turkey were contacted to determine if they were eligible to participate in the study. Centers that were eligible and agreed to participate were sent a database form to record the demographic characteristics, clinicopathologic findings, and follow-up results for their EC patients. Results: Eleven Turkish healthcare centers provided data on 43 EC patients. Mean duration of treatment was 5 months and mean follow-up was 49 months. In total, 35 (81.4%) patients were tumor free following primary progesterone therapy. Mean time from the end of progesterone therapy to pregnancy was 10.6 +/- 4.3 months (range, 3-18 months). Two patients had tumor recurrence during follow-up. The pregnancy rate among the 31 women who actively sought pregnancy was 41.9% (n = 13). Conclusion: Conservative management of early-stage EC in women of reproductive age using oral progestins was effective and did not compromise oncological outcome. Pregnancy in the study patients was achieved spontaneously and artificially. (C) 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.Item Internalized stigma in psoriasis: A multicenter studyAlpsoy, E; Polat, M; Fettahlioglu-Karaman, B; Karadag, AS; Kartal-Durmazlar, P; Yalcin, B; Emre, S; Didar-Balci, D; Bilgic-Temel, A; Arca, E; Koca, R; Gunduz, K; Borlu, M; Ergun, T; Dogruk-Kacar, S; Cordan-Yazici, A; Dursun, P; Bilgic, O; Gunes-Bilgili, S; Sendur, N; Baysal, O; Halil-Yavuz, I; Yagcioglu, G; Yilmaz, E; Kavuzlu, U; Senol, YInternalized stigma is the adoption of negative attitudes and stereotypes of the society regarding a person's illness. It causes decreased self-esteem and life-satisfaction, increased depression and suicidality, and difficulty in coping with the illness. The primary aim of this study was to investigate the internalized stigma state of psoriatic patients and to identify the factors influencing internalized stigma. The secondary aim was to identify the correlation of internalized stigma with quality of life and perceived health status. This multicentre, cross-sectional study comprised 1485 patients. There was a significant positive correlation between mean values of Psoriasis Internalized Stigma Scale (PISS) and Psoriasis Area and Severity Index, Body Surface Area, Dermatological Life Quality Index and General Health Questionnaire-12 (P < 0.001 in all). Lower percieved health score (P = 0.001), early onset psoriasis (P = 0.016), family history of psoriasis (P = 0.0034), being illiterate (P < 0.001) and lower income level (P < 0.001) were determinants of high PISS scores. Mean PISS values were higher in erythrodermic and generalized pustular psoriasis. Involvement of scalp, face, hand, genitalia and finger nails as well as arthropathic and inverse psoriasis were also related to significantly higher PISS scores (P = 0.001). Our findings imply that psoriatic patients experience high levels of internalized stigma which are associated with psoriasis severity, involvement of visible body parts, genital area, folds or joints, poorer quality of life, negative perceptions of general health and psychological illnesses. Therefore, internalized stigma may be one of the major factors responsible from psychosocial burden of the disease.Item Internalized Stigma in Pediatric Psoriasis: A Comparative Multicenter StudyAlpsoy, E; Polat, M; Yavuz, IH; Kartal, P; Balci, DD; Karadag, AS; Bilgic, A; Arca, E; Karaman, BF; Emre, S; Adisen, E; Sendur, N; Bilgic, O; Yazici, AC; Yalcin, B; Koca, R; Gunduz, K; Borlu, M; Ergun, T; Dursun, P; Bilgili, SG; Adanir, AS; Gulekon, A; Yagcioglu, G; Yilmaz, E; Kavuzlu, U; Senol, YBackground: Internalized stigma, adoption of negative attitudes and stereotypes of the society regarding persons' illness, has not been studied previously in pediatric psoriasis patients. Objective: We aimed to investigate the internalized stigma in pediatric psoriasis patients and to determine differences according to factors affecting internalized stigma compared to adult psoriasis patients. Methods: This multicenter, cross-sectional, comparative study included 125 pediatric (55 female, 70 male; mean age +/- standard deviation [SD], 14.59 +/- 2.87 years) and 1,235 adult psoriasis patients (577 female, 658 male; mean age +/- SD, 43.3 +/- 13.7 years). Psoriasis Internalized Stigma Scale (PISS), Dermatology Life Quality Index (DLQI), Perceived Health Status (PHS), and the General Health Questionnaire (GHQ)-12 were the scales used in the study. Results: The mean PISS was 58.48 +/- 14.9 in pediatric group. When PISS subscales of groups were compared, the pediatric group had significantly higher stigma resistance (p = 0.01) whereas adult group had higher scores of alienation (p = 0.01) and stereotype endorsement (p = 0.04). There was a strong correlation between mean values of PISS and DLQI (r = 0.423, p = 0.001). High internalized stigma scores had no relation to either the severity or localization of disease in pediatric group. However, poor PHS (p = 0.007) and low-income levels (p = 0.03) in both groups, and body mass index (r = 0.181, p = 0.04) in the pediatric group were related to high PISS scores. Conclusion: Internalized stigma in pediatric patients is as high as adults and is related to poor quality of life, general health, and psychological illnesses. Unlike adults, internalized stigma was mainly determined by psoriasis per se, rather than disease severity or involvement of visible body parts, genitalia or folds.